Patricia Garrido-Munoz

Copenhagen, 2200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.

MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.

Journal: Journal of hepatology

Published: March 29, 2022

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.

Journal: Journal of hepatology

Published: September 29, 2021

Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer.

Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer.

Journal: British journal of cancer

Published: July 06, 2021

The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.

The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 01, 2020

Molecular Targets in Cholangiocarcinoma.

Molecular Targets in Cholangiocarcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: March 05, 2020

Current and novel therapeutic opportunities for systemic therapy in biliary cancer.

Current and novel therapeutic opportunities for systemic therapy in biliary cancer.

Journal: British journal of cancer

Published: March 03, 2020

Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets.

Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 17, 2019

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.

Journal: Hepatology (Baltimore, Md.)

Published: October 18, 2019

The jigsaw of dual hepatocellular-intrahepatic cholangiocarcinoma tumours.

The jigsaw of dual hepatocellular-intrahepatic cholangiocarcinoma tumours.

Journal: Nature reviews. Gastroenterology & hepatology

Published: July 13, 2019

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.

Journal: Gut

Published: June 04, 2019

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.

Journal: Journal of Crohn's & colitis

Published: May 08, 2019

Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.

Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.

Journal: Hepatology (Baltimore, Md.)

Published: June 27, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026